Recent studies have also shown the correlation between ETBF and molecular features of CRC, suggesting that an ETBF-rich microbiome may be related to specific CRC subtypes.58 This finding echoes our view that KRAS mutations and the microbiome may both contribute to the molecular pathogenesis of CRC. This evidence concerns the gene KRAS and colorectal carcinoma.